Vertex Pharmaceuticals News

Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone

Alpine Immune Sciences (ALPN) and Vertex Pharmaceuticals (VRTX) said Friday the waiting period under the Hart-Scott-Rodino antitrust act related to their merger deal expired Thursday. Vertex has agree

MT NewswiresMay 11 03:32

HHS Panel to Vote in Nov. on DMD Screening for Newborns

Seeking AlphaMay 10 06:44

Press Release: Alpine Immune Sciences Reports First Quarter 2024 Financial Results

Alpine Immune Sciences Reports First Quarter 2024 Financial Results SEATTLE--(BUSINESS WIRE)--May 09, 2024-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy compa

Dow JonesMay 10 04:00

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) CEO Will Probably Have Their Compensation Approved By Shareholders

We have been pretty impressed with the performance at Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) recently and CEO Reshma Kewalramani deserves a mention for their role in it.

Simply Wall StMay 9 20:48

Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight

Vertex Pharmaceuticals Inc (NASDAQ:VRTX), a leading global biotechnology firm, recently released its 10-Q filing on May 7, 2024, offering a detailed glimpse into its financial and operational performance.

Yahoo FinanceMay 9 13:04

Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)

In a report released yesterday, Paul Matteis from Stifel Nicolaus maintained a Hold rating on Vertex Pharmaceuticals (VRTX), with a price target of $420.00.

TipRanksMay 9 10:07

A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics

Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals.

BenzingaMay 9 02:45

Balancing Act: Vertex Pharmaceuticals' Growth Prospects and Valuation Concerns Justify a Hold Rating

TipRanksMay 8 22:48

Vertex Pharmaceuticals Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) investors will be delighted, with the company turning in some strong numbers with its latest results. Vertex Pharmaceuticals beat earnings, with

Simply Wall StMay 8 20:45

Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceMay 8 20:30

Vertex Pharmaceuticals Sell Rating Maintained Amid Unsustainable Performance and Uncertain Pipeline Progress

TipRanksMay 8 19:32

5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip

Yahoo FinanceMay 8 17:43

Sell Rating on Vertex Pharmaceuticals Amid Non-Recurring Gains and Overstated Sales

TipRanksMay 8 12:35

Vertex Pharmaceuticals | 10-Q: Quarterly report

Futu NewsMay 8 04:50 · Announcements

10 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.

BenzingaMay 8 01:35

US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?

Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data and minimal updates on earnings from major large-cap companies.Traders larg

BenzingaMay 8 01:18

Apple's $110B Buyback Is Larger Than the Market Caps of 418 S&P 500 Stocks

Seeking AlphaMay 7 21:01

Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 7 20:17

HC Wainwright & Co. Reiterates Buy on Vertex Pharmaceuticals, Maintains $462 Price Target

HC Wainwright & Co. analyst Andrew Fein reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and maintains $462 price target.

BenzingaMay 7 19:45

Vertex Pharmaceuticals (VRTX) Receives a Buy From Barclays

TipRanksMay 7 19:43